Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro
- 15 January 2012
- journal article
- Published by Elsevier BV in Toxicology and Applied Pharmacology
- Vol. 258 (2), 166-175
- https://doi.org/10.1016/j.taap.2011.10.018
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Comparison of Gene Expression Profiles in Chromate Transformed BEAS-2B CellsPLOS ONE, 2011
- Mitogen-Activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways?Journal of Signal Transduction, 2011
- Hexavalent chromium-induced apoptosis of granulosa cells involves selective sub-cellular translocation of Bcl-2 members, ERK1/2 and p53Toxicology and Applied Pharmacology, 2011
- The Dual Roles of c-Jun NH2-Terminal Kinase Signaling in Cr(VI)-Induced Apoptosis in JB6 CellsToxicological Sciences, 2010
- Mechanisms of Base Selection by Human Single-stranded Selective Monofunctional Uracil-DNA GlycosylasePublished by Elsevier BV ,2009
- Nickel compounds induce apoptosis in human bronchial epithelial Beas-2B cells by activation of c-Myc through ERK pathwayToxicology and Applied Pharmacology, 2009
- Superoxide-mediated proteasomal degradation of Bcl-2 determines cell susceptibility to Cr(VI)-induced apoptosisCarcinogenesis: Integrative Cancer Research, 2008
- DNA damage signalling guards against activated oncogenes and tumour progressionOncogene, 2007
- Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectivesPhytochemistry, 2006
- Chromium VI-Induced Apoptosis in a Human Bronchial Epithelial Cell Line (BEAS-2B) and a Lymphoblastic Leukemia Cell Line (MOLT-4)Journal of Occupational and Environmental Medicine, 2006